VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer
VELRAD
Videoendoscopic Radical Inguinal Lymphadenectomy Versus Open Radical Inguinal Lymphadenectomy in Patients With Penile Cancer: a Feasibility Randomised Controlled Trial
1 other identifier
interventional
50
1 country
1
Brief Summary
Assess the feasibility of performing a RCT comparing videoendoscopic radical inguinal lymphadenectomy versus open radical inguinal lymphadenectomy in men diagnosed with genital cancer requiring inguinal lymphadenectomy, and determine the design of such an RCT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 23, 2022
CompletedFirst Submitted
Initial submission to the registry
October 13, 2022
CompletedFirst Posted
Study publicly available on registry
October 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedMay 16, 2025
May 1, 2025
2.9 years
October 13, 2022
May 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Ability to recruit patients
Ability to recruit patients at the selected sites (recruitment rate)
18 months
Study Arms (2)
Videoendoscopic Inguinal Lymphadenectomy
ACTIVE COMPARATORRemoval of inguinal nodes using Videoendoscopic Inguinal Lymphadenectomy
Open Inguinal Lymphadenectomy
OTHERRemoval of inguinal nodes using Open radical inguinal lymphadenectomy
Interventions
Intervention is a Videoendoscopic radical inguinal lymphadenectomy (VEIL) which is a surgical technique utilised in removing inguinal lymph nodes.
Eligibility Criteria
You may qualify if:
- People requiring inguinal lymphadenectomy i.e.
- Patients with squamous cell carcinoma or mucosal melanoma of the penis \> T1bG2 or patients with male genital cancer requiring inguinal lymphadenectomy
- Patients unsuitable for dynamic sentinel node biopsy (DSNB) with impalpable nodes: previous penectomy or non-visualisation at previous DSNB
- Previous DSNB with metastatic inguinal nodes on histology or FNA positive nodes on cytology who require a completion radical inguinal lymphadenectomy
- Small volume palpable inguinal lymph nodes (\< 2 cm on CT) not fixed to skin
- Age \> 18 years
You may not qualify if:
- Unfit for surgery
- People unlikely to benefit from lymphadenectomy because of advanced cancer
- Those with palpable inguinal lymph nodes fixed to skin or adjacent structures
- Does not want to participate in the trial or unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University College London
London, London, NW1 2BU, United Kingdom
Related Publications (1)
Tang S, Akers C, Alnajjar H, Ayres B, Baldini C, Embleton-Thirsk A, Gurusamy K, Hadway P, Kumar V, Lau M, Nigam R, Pang K, Parnham A, Pizzo E, Ranieri V, Rees R, Sangar V, Wadke A, Williams N, Muneer A. A study protocol for a feasibility randomised controlled trial investigating videoendoscopic radical inguinal lymphadenectomy versus open radical inguinal lymphadenectomy in patients with penile cancer (VELRAD). Pilot Feasibility Stud. 2024 Apr 10;10(1):61. doi: 10.1186/s40814-024-01474-8.
PMID: 38600541DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Asif Muneer, MD
University College, London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2022
First Posted
October 25, 2022
Study Start
June 23, 2022
Primary Completion
May 1, 2025
Study Completion
July 1, 2025
Last Updated
May 16, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share